KOD

Conviction 66HealthcareScan · Mon, Aug 10, 2026

KOD$43.39-4.36%

ResistanceSupportVol 14Insider sell

Vol MA14 557.96K

May 11May 28Jun 16Jul 6Jul 23Aug 10

Kodiak Sciences Inc.BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.kodiak.com ↗

Price43.39

Change-4.36%

Gap+0.51%

Rel volume1.29×

Avg volume565.25K

Avg $ vol23.9M

SMA 2042.20

SMA 5038.39

SMA 20031.20

Price vs 50+13.02%

Price vs 200+39.08%

MA stackbullish

50/200 cross—

Supertrendup · 37.93

RSI (14)56

MACD hist0.15

MACD crossbull · 2d

Stoch %K / %D60 / 78

ADX (14)16

+DI / −DI21 / 17

RSI divergence—

MACD divergence—

ATR %+6.38%

ADR %6.57%

52w high46.44

52w low7.90

From 52w high-6.57%

Above 52w low+449.24%

New 52w highNo

SqueezeOn · 12d

Bollinger width14.21%

%B0.70

Donchian pos60.45%

Donchian high46.87

Donchian low38.07

AVWAP (52w high)38.56

vs AVWAP high+12.53%

AVWAP (52w low)27.84

vs AVWAP low+55.85%

OBV trendFlat

Chaikin MF (20)0.00

Today vs 20d1.29×

Avg vol (14d)557.96K

Avg vol (20d)565.25K

Avg $ vol (20d)23.9M

Market cap2.72B

RS 3m (vs SPY)-1.83%

RS 6m (vs SPY)+101.83%

RS line new highNo

Trend template7/8

Technical rank85.4

1 week+8.94%

1 month+5.04%

3 months+5.80%

6 months+88.32%

1 year+429.15%

YTD+66.76%

P/E-11.81

P/B24.22

P/S—

P/FCF-19.89

EPS-4.32

Div yield—

ROE-205.14%

ROA-75.15%

Debt/Eq—

Current3.54

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-30.51%

Price target62.50

Target upside44.04%

Analyst ratingBuy

Institutional97.66%

Ent. value2.55B

Revenue—

Net income-58.16M

Gross profit—

Free cash flow-136.51M

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out62.58M

Employees124

ListedThu, Oct 4, 2018

Free float28.06M

Float %45.4%

Short interest10.42M

Days to cover13.7d

Short volume44.2%

Squeeze score72 / 100

Next earnings—

EPS forecast—

Last EPS vs est−$0.94 vs −$0.93

Last surprise-1.1% miss

Setup gradeB

Conviction66 / 100

Pattern quality—

Tech rank85.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance44.57

Support33.01

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KOD

All disclosures →

No recent disclosed trades by Congress in KOD. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KOD · 4 buys · 4 sells

Insider	Side	Shares	Value	Traded	Filed
BORGESON JOHN A. Chief Financial Officer · Stock Option (Right to Buy) · 2026-07-15	Grant	66.5K	—	2026-07-15	2026-07-17
PERLROTH VICTOR Chairman and CEO · Stock Option (Right to Buy) · 2026-07-15	Grant	100K	—	2026-07-15	2026-07-17
BORGESON JOHN A. Chief Financial Officer · Stock Option (Right to Buy) · 2026-06-04	Exercise	30K	$0	2026-06-04	2026-06-05
BORGESON JOHN A. Chief Financial Officer · Common Stock · 2026-06-04	Sell	25.9K	$881K	2026-06-04	2026-06-05
BORGESON JOHN A. Chief Financial Officer · Common Stock · 2026-06-04	Exercise	30K	$31K	2026-06-04	2026-06-05
BORGESON JOHN A. Chief Financial Officer · Common Stock · 2026-06-04	Sell	4.1K	$142K	2026-06-04	2026-06-05
BORGESON JOHN A. Chief Financial Officer · Common Stock · 2026-04-15	Exercise	28.61K	$30K	2026-04-15	2026-04-16
BORGESON JOHN A. Chief Financial Officer · Stock Option (Right to Buy) · 2026-04-15	Exercise	28.61K	$0	2026-04-15	2026-04-16

SEC filings

EDGAR filings in KOD · 2 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.